Bioray Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	222.73	201.71	191.83	190.6	148.02
Revenue Growth (YoY)	10.42%	5.15%	0.65%	28.77%	-5.30%
Cost of Revenue	116.79	122.69	114.18	110.09	80.73
Gross Profit	105.94	79.03	77.65	80.51	67.29
Selling, General & Admin	43.29	47.66	52.73	48.48	53.55
Research & Development	24.86	35.25	44.27	32.26	21.86
Operating Expenses	68.04	83.34	96.98	80.82	75.4
Operating Income	37.9	-4.32	-19.33	-0.31	-8.11
Interest Expense	-0.65	-1.33	-1.32	-1.36	-0.95
Interest & Investment Income	1.19	1.27	0.65	0.19	0.05
Currency Exchange Gain (Loss)	-	0.18	-0.18	-0.13	-0.18
Other Non Operating Income (Expenses)	2.8	5.02	7.09	2.12	3.02
EBT Excluding Unusual Items	41.24	0.83	-13.09	0.5	-6.17
Impairment of Goodwill	-	-	-1.3	-	-
Gain (Loss) on Sale of Assets	-	-0.05	0.2	0.18	-
Other Unusual Items	-	0.6	-	-	-
Pretax Income	41.24	1.38	-14.19	0.68	-6.17
Income Tax Expense	8.99	0.38	-2.63	0.18	1.76
Earnings From Continuing Operations	32.25	1	-11.56	0.5	-7.93
Minority Interest in Earnings	-	-	-	-	0.74
Net Income	32.25	1	-11.56	0.5	-7.19
Net Income to Common	32.25	1	-11.56	0.5	-7.19
Net Income Growth	3118.56%	-	-	-	-
Shares Outstanding (Basic)	30	30	30	28	27
Shares Outstanding (Diluted)	30	30	30	28	27
Shares Change (YoY)	-0.83%	-0.83%	7.37%	4.67%	0.14%
EPS (Basic)	1.09	0.03	-0.38	0.02	-0.27
EPS (Diluted)	1.09	0.03	-0.38	0.02	-0.27
EPS Growth	3533.33%	-	-	-	-
Free Cash Flow	71.27	13.43	-10.78	-57.16	-6.15
Free Cash Flow Per Share	2.41	0.45	-0.36	-2.04	-0.23
Dividend Per Share	-	-	-	0.200	-
Gross Margin	47.56%	39.18%	40.48%	42.24%	45.46%
Operating Margin	17.02%	-2.14%	-10.08%	-0.16%	-5.48%
Profit Margin	14.48%	0.50%	-6.03%	0.26%	-4.86%
Free Cash Flow Margin	32.00%	6.66%	-5.62%	-29.99%	-4.15%
EBITDA	61.49	12.05	-1.66	15.79	5.32
EBITDA Margin	27.61%	5.97%	-0.86%	8.29%	3.59%
D&A For EBITDA	23.59	16.37	17.67	16.11	13.43
EBIT	37.9	-4.32	-19.33	-0.31	-8.11
EBIT Margin	17.02%	-2.14%	-10.08%	-0.16%	-5.48%
Effective Tax Rate	21.80%	27.39%	-	26.69%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.